News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →GRVT Burns 1.1 Million Tokens as Countdown to Grvt 2.0 Begins
<strong>[PRESS RELEASE – Singapore, Singapore, October 20th, 2026]</strong> <strong>The discretionary buyback represents close to 1% of circulating supply and precedes four planned product milestones culminating in Grvt 2.0.</strong> <a href="https://grvt.io/" rel="nofollow noopener" target="_blank">>Grvt</a>, a self-custodial trading platform built on its own zero-knowledge (ZK) chain, announced that the Foundation’s token issuer has completed its first GRVT token buyback, purchasing and burning 1.1 million GRVT tokens on the open market. The transaction permanently removed close to 1% of GRVT’s circulating supply at the time of purchase. It marks the first of five milestones ahead of the planned launch of Grvt 2.0 at the end of November 2026. <strong>A Discretionary Buyback with On-Chain Verification</strong> The Foundation’s token issuer intends to conduct further buybacks on a monthly basis. Each transaction remains entirely at the issuer’s discretion, with no predetermined purchase amount or guaranteed schedule. Buybacks are executed through an independent execution partner, with purchased tokens transferred to a designated burn address and permanently removed from circulation. The transactions can be independently verified through the <a href="https://grvt.io/exchange/buybacks" rel="nofollow noopener" target="_blank">>public buyback dashboard</a>, which records the number of tokens purchased and burned, the percentage of circulating supply represented, cumulative burns and on-chain transaction hashes. “The GRVT token is an important part of the ecosystem we are building,” said <strong>Hong, co-founder and CEO of Grvt</strong>. “We welcome the issuer’s buybacks as a demonstration of its long-term commitment to the ecosystem and community. Grvt is expanding its products and markets, and the issuer’s buybacks sit alongside that as a supportive mechanism aimed at reducing circulating token supply.” <strong>Grvt Outlines Four Product Milestones</strong> The announcement follows GRVT’s token generation event in July 2026 and precedes a series of planned launches. <strong>Grvt Earn, scheduled for the End of October,</strong> will introduce yield opportunities backed by tokenized assets, with target yields of up to 11%. Potential returns are expected to derive from underlying asset cash flows, including interest, premiums and invoice-related income. Asset-supplying partners will be announced at launch. Target yields are not guaranteed. <strong>Stable Funding Perps, scheduled for November,</strong> will introduce perpetual futures linked to commodities, stocks, foreign exchange and indices. The contracts are planned to carry zero trading fees and use once-daily funding. Grvt aims to list more than 1,000 markets by the end of December 2026. <strong>Yield as Margin, also scheduled for November,</strong> will allow eligible Grvt Earn balances to support trading positions while continuing to accrue yield, subject to applicable product terms
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
UK October CPI data released
CoinWorld data: UK October consumer price index (CPI) rose 0.4% month-on-month, versus expectations of 0.3%, and rose 3.5% year-on-year, versus expectations of 3.4%. Core CPI rose 0.2% month-on-month, in line with expectations, and rose 2.8% year-on-year, also in line with expectations.
SPY off-exchange short sale volume ratio reported at 45.58%
BiJie Network US stock data: SPY's off-exchange short selling volume accounted for 45.58% of the total that day. Compared with the same-caliber snapshot 24 hours earlier, it rose by 0.1498 percentage points; compared with the same-caliber snapshot 7 days earlier, it fell by 10.2941 percentage points.
Russian President Putin: After Russia and the US made decisions on diesel fuel, international market prices fell by 5% to 6%.
According to CoinWorld news, Russian President Putin: After Russia and the United States made a decision on diesel fuel, international market prices fell by 5% to 6%.
An address with a 100% win rate closed a 104.81 BTC position, earning a profit of $476,300.
CoinWorld data: Address 0xf517…c032 completed 37 rounds of BTC trading between September 18 and October 21, 2026. From 15:02 on October 21, 2026 to 00:50 on October 22, 2026 (UTC+8), the address closed 104.81 BTC, worth approximately 8.6991 million USD, for a profit of 476,300 USD. The weighted average closing price for this close was approximately 83,068 USD, and the weighted average opening price was approximately 82,972 USD.
Jensen Huang is pitching AI to Europe, and countries may become more dependent on Nvidia.
CoinWorld news: Jensen Huang has been vigorously promoting the prospects of artificial intelligence across Europe, warming up for his keynote speech at Nvidia's flagship conference soon to be held in Berlin. He stressed that the next round of AI spending will come from governments, which regard AI as a necessity for national development rather than a speculative bet. In the AI era, countries eager to safeguard their independence may become more dependent than ever on a single American company.
NVIDIA CEO Jensen Huang: Artificial intelligence will affect everything.
CoinWorld news: Nvidia CEO Jensen Huang has recently made a series of remarks, stating that artificial intelligence will affect everything we build and enable us to build new things. He pointed out that we are at the starting point of a new industrial revolution and emphasized that artificial intelligence is not merely a software technology.
Jensen Huang is pitching AI to Europe, and countries may become more dependent on Nvidia.
Jensen Huang is vigorously promoting the prospects of artificial intelligence across Europe, emphasizing that governments view AI as a national development necessity rather than a speculative bet. His keynote speech will take place at Nvidia's flagship conference in Berlin and is expected to offer an opportunity to reassure investors.
Kaito multisig address transfers 8 million tokens, possibly related to the 10.20 unlock.
According to CoinWorld news, the Kaito multisig address transferred 8 million Kaito tokens to address 0xd21…b2629 40 minutes ago, worth approximately $2.25 million at current prices. This intermediary address had previously received 7 million tokens from the same source three months ago, which may be related to the 12.1 million token unlock on October 20, representing 5.01% of the circulating market cap.